Prof dr Karel Allegaert, MD, PhD is pediatrician-neonatologist and clinical pharmacologist. He is associate Professor at KU Leuven (2016-2018, 20%) and Consultant at MC Rotterdam (2016-2018, 80%). He is president of the European Society for Developmental Pharmacology and is former Board Member of the European Society for Pediatric Research (section clinical pharmacology). Specific interests in the fields of perinatal clinical pharmacology and neonatal intensive care.
Dr Anderson is a neuropsychologist based at the Monash Institute of Cognitive and Clinical Neurosciences, and director of the Victorian Infant Brain Studies (VIBeS) team at the Murdoch Childrens Research Institute. His research program focuses on high risk neonates, particularly infants born very preterm. Dr Anderson seeks to understand the factors underpinning the variability in long-term outcomes in cognitive, motor, academic, behavioural and social functioning. He is involved in large observational and neuroimaging studies, as well as clinical trials.
Ola Andersson, MD, PhD is board certified in Paediatrics and Neonatology. His is working as a consultant at the Paediatrics department at Hospital of Halland, where he also holds a position as medical director at the Research and Development department. He is affiliated to Uppsala University and have conducted to randomised controlled trials on term infants and umbilical cord clamping in Sweden and Nepal. Presently, he is PI for a study on bedside resuscitation without cord clamping in Nepal.
Anna Axelin, RN, PhD, Adjunct Professor is the Director for Separation and Closeness Experiences in the Neonatal Environment (SCENE) research group and a University Research Fellow in the Department of Nursing Science at the University of Turku, Finland. Her academic career has included conducting quantitative and qualitative research in multidisciplinary research groups. Her main research interest is family centered care in neonatal context.
Olga Basso is Associate Professor of epidemiology at McGill University (Canada) since 2010. Educated in Pavia, Italy, she has worked at the Danish Epidemiology Science Centre (Denmark) and the National Institutes of Environmental Health Sciences (USA). Her research focuses on the methodologic and substantive aspects of studying complex determinants, such as preterm birth and infertility, in reproductive epidemiology.
Olivier Baud is a neonatologist and neuroscientist. His main clinical research interests are chronic lung disease, brain vulnerability/neuroprotection following preterm delivery, and impact of IUGR on the developing brain.
He was research fellow at Children’s hospital, Boston, Harvard Medical School in 2003. He founded his own research Inserm team in 2006, a team that is becoming a leader in translational research on neuroprotection and repair of the developing brain. The main focus of this basic research team is physiopathology of developing brain damages and perinatal neuroprotection.
Olivier Baud is full professor of Pediatrics at Paris-Diderot University since 2006 and is PI at Inserm Unit 1141 in Paris. He was recently appointed to Geneva children’s hospital and University of Geneva.
He is involved in the teaching of several courses in pediatrics and neuroscience. More than 100 invited conferences and seminars are at his credit. He has trained several young medical and non-medical scientists from various countries. He is currently academic editor for PlosONE. He collected more than 6M€ from 2006 as research grants including 2 major clinical RCTs as PI and one European Research Contract as Co-PI (Fusimagine).
General Secretary of Union
of European Neonatal and Perinatal Societies (UENPS)
President of Hungarian Society
of Perinatology and Obstetric Anesthesiology
General Secretary of Hungarian Society
I am an early-stage clinician-scientist, trained in one of the French MD-PhD programs, graduating in chemistry and anaesthesiology/intensive care. I have a special interest in neonatal and paediatric anaesthesia and intensive care. I use spectroscopic approaches, such as nuclear magnetic resonance and mass spectrometry, to decipher metabolic changes that can be connected to various pathophysiological conditions.
Geraldine Boylan is Professor of Neonatal Physiology, Department of Paediatrics & Child Health, University College Cork, Ireland and Director of the Irish Centre for Fetal and Neonatal Translational Research – INFANT www.infantcentre.ie
Geraldine has worked in the area of clinical neurophysiology for many years and since 1996 has worked exclusively in the field of neonatal neurophysiology.
She leads the Neonatal Brain Research Group at the INFANT centre – a multidisciplinary research team focused on neurological monitoring of infants in the neonatal intensive care unit, particularly for seizure detection and the early diagnosis of brain injury. Researchers in the team develop automated algorithms for monitoring newborn brain activity and monitoring tools for physiological data acquisition. They developed a novel seizure detection algorithm for newborn infants which was recently evaluated in a Wellcome Trust funded clinical trial across 8 centres in Europe www.anserstudy.com.
María Carmen Bravo Laguna, MDPhD
Department of Neonatology
La Paz University Hospital
Paseo de la Castellana 261
Fax: +34 917277362
Department of Neonatology, La Paz University Hospital, Spain
I am currently undertaking a PhD on the use of novel echocardiography techniques in the assessment of myocardial performance in infants with various important disease conditions. My special area of interest is paediatric cardiology and haemodynamic processes in neonatal patients and children.
Dr. Marsha Campbell-Yeo is a certified neonatal nurse practitioner, an Associate Professor at Dalhousie University School of Nursing, and a Clinician Scientist at the IWK Heath Centre with cross appointments to the Departments of Pediatrics, and Psychology and Neuroscience. She maintains .2 in the NICU in the role of a neonatal nurse practitioner. Her research lab, primarily funded by the Canadian Institute of Health Research and Canadian Foundation of Innovation Grant, entitled “Mechanisms, Outcomes, and Mobilization of maternally-Led Interventions for Newborn Care” (MOM-LINC), provides an interdisciplinary research environment for the development of innovative and non-invasive healthcare interventions that engage mothers and families in the management and care of neonates.
She currently holds a Canadian Institute of Health Research (CIHR) New Investigator Award (2017-2021), an Career Development Award from the Canadian Child Health Clinician Scientist Program Award (2015-2019) and she has been the recipient of the Canadian Pain Society Early Career Award (2015), Excellence in Nursing Research Award (2014);, College of Registered Nurses of Nova Scotia (2014); Global Health REAL Award (2013); and CIHR fellowship (2008-2012). She is a mentor in the Pain in Child Health (PICH) training program.
Dr. Campbell-Yeo is the Secretary on the Board of Directors for the Canadian Pain Society (2014-2017), and is an elected Council Member for the IASP Special Interest Group on Pain in Childhood (2015-2020). Dr. Campbell-Yeo is a Mayday Pain and Society Fellow.
Research Associate Professor of Pediatrics, Director, Neonatal Pulmonary Research Laboratory, Division of Neonatology, Department of Pediatrics, University of Miami Miller School of Medicine
I am a neonatal nurse practitioner. Besides clinical work I focus mainly on the Case Management for the extreme premature born children and the development of involving parents in direct care.
Prof. Dargaville trained in Neonatology at the Royal Children’s Hospital, Melbourne, and at the University of California, San Francisco. His training included a two year full-time research project looking at pulmonary surfactant and its abnormalities in ventilated infants with lung disease, for which he was awarded an MD from the University of Melbourne in 2000.
He now continues as a clinician-researcher at the Royal Hobart Hospital and Menzies Institute, University of Tasmania. The major focus of his research is the development and implementation of new therapies for neonatal lung disease. His endeavours have led to the completion of an NHMRC-funded multinational clinical trial on surfactant lavage therapy in meconium aspiration syndrome, and more recently to the conduct of a randomised controlled trial of minimally invasive surfactant therapy in preterm infants with respiratory distress syndrome (the OPTIMIST-A trial). He also leads a research team that has developed and evaluated a novel algorithm for automated oxygen control in preterm infants with respiratory insufficiency. Other projects include elucidation of the physiological principles of neonatal mechanical ventilation, and optimisation of lung volume during high frequency oscillatory ventilation.
Dr Peter Davis is the Professor/Director of Neonatal Medicine at The Royal Women’s Hospital, Melbourne. He has led the Department of Newborn Research since 2009.
He completed his MBBS at the University of Queensland in 1982 and underwent basic paediatric training in Brisbane. He completed his neonatal fellowship training at McMaster University, Canada where he developed an interest in Clinical Epidemiology and Evidence Based Medicine. After returning to Australia in 1993, he was appointed as a consultant neonatologist at The Royal Woman’s Hospital, Melbourne.
His interest in non-invasive ventilation led to an MD through the University of Melbourne in 1998. He leads a young team of enthusiastic clinical researchers interested in improving the care of babies in the delivery room and in the intensive care unit. He is a substantial contributor to the Cochrane Collaboration and a member of the neonatal subcommittee of the International Liaison Committee on Resuscitation (ILCOR). Support for his research comes from the Australian National Health and Medical Research Council through a Practitioner Fellowship, a Program Grant and a Centre for Research Excellence Grant. Other project support comes from the Australian government and NIH, Dr Davis has more than 300 peer reviewed publications and is on the editorial board of three international journals.
Willem de Boode obtained his medical degree at the Free University of Amsterdam in the Netherlands. Since 1999 he is member of staff of the Department of Neonatology of the Radboudumc Amalia Children’s Hospital in Nijmegen, The Netherlands, where he was trained in Paediatrics and Neonatology. His areas of interest are neonatal haemodynamics, extracorporeal life support, acid-base balance (Stewart approach), neonatal surgery, and neonatal intensive care transport.
The focus of his research is on Advanced Haemodynamic Monitoring. He is involved in both experimental and clinical research. In 2010 he defended his thesis, entitled “Neonatal hemodynamic monitoring. Validation in an experimental animal model”.
Willem de Boode is founder and chairman of the “Dutch Working Group on Neonatal Haemodynamics”, council member of the European Society for Paediatric Research (ESPR) and secretary of the Section “Circulation, Oxygen Transport and Haematology” of the ESPR.
Willem is chairing the ESPR/ESN special interest group “Neonatologist Performed Echocardiography”, that is formulating European guidelines regarding the use of echocardiography on the NICU. He is the project leader of the BeNeDuctus Trial, an international multi-center, randomized non-inferiority trial of early treatment versus expectative management of patent ductus arteriosus in preterm infants, that is funded by The Netherlands Organization for Health Research and Development (ZonMw) – ClinicalTrials.gov Identifier: NCT02884219.
Willem de Boode is happily married and father of 4 children. His hobbies are drumming, boat building and theatre.
Jurgen de Graaff is anaesthesiologist (2008) and epidemiologist (2004). He studied Medicine at the University of Maastricht (1996) and obtained his PhD at the Academic Medical Center, University of Amsterdam (2003) on the thesis entitled: “The use of microcirculatory techniques in the assessment of pathophysiology, diagnosis and management of critical limb ischemia”.
After he was trained at the St. Antonius Hospital, Nieuwegein (2008) he became a staff anesthesiologist at the Wilhelmina Children’s Hospital (2009). He was a visiting researcher at the Royal Children’s Hospital in Melbourne (2012). Since 2016 he is working at the Sophia Children’s Hospital, Erasmus Medical Center Rotterdam.
He is Honorary Secretary of the European Society for Paediatric Anaesthesiology (2016), and vice president of the Dutch Society for Paediatric Anaesthesia (2013).
His research focuses on the improvement of perioperative care in children using retrospective and prospective pre- and intraoperative (database) studies. Furthermore, he is a member of the Trial Steering Committee and Management Group of the GAS-study and national coordinator of the Nectarine study. He has published more than 40 papers in international papers and is an invited speaker at national and international conferences and a reviewer of various international scientific journals. He has received the ESA Research Support Grant 2013 and Philips Grant 2015.
Prof. Daniele De Luca received his MD license from the Catholic University of the Sacred Heart in Rome, Italy in 2001. Prof. De Luca completed his Master’s degrees at the same university in Paediatric Emergencies in 2003 and Neonatal Pulmonology in 2005. He received a Fellowship in Paediatrics and Neonatal Critical Care from the same university in 2007.
He is now the Medical Director of the Division of Paediatrics and Neonatal Critical Care and Associate Professor of Neonatology at South Paris University, “A.Beclere” Medical Centre, in Paris, France. He is also the Contract Professor of Neonatal and Paediatric Critical Care Catholic University of the Sacred Heart in Rome, Italy.
Prof De Luca has published approximately 150 papers for journals with an impact factor > 300, an H-Index of 18, and has been a referee for several major paediatric and general journals. He has been a referee for international grants and research quality programs in EU, Germany, Netherlands, UK, Canada, France, Italy, and South Africa. Dr De Luca is the Secretary of the European Society for Paediatric and Neonatal Intensive Care (ESPNIC) and Council member of the European Society for Pediatric Research (ESPR).
Professor Dempsey is a Science Foundation Ireland Principal Investigator within INFANT.
He has significant experience in conducting newborn clinical trials. His principle area of interest is cardiovascular support in the preterm infant. He is the lead PI for a number of on-going SFI funded studies including Neuroprobe, a study addressing the relationship between blood pressure and cerebral activity in preterm infants.Other areas of interest include ethical issues pertaining to the newborn infant, manual ventilation, newborn resuscitation training, simulation based procedural healthcare, enhanced newborn stabilization, cerebral oxygenation and the role of NIRS in delivery suite management. He has acted as an international reviewer for a number of funding agencies including the NIHR and the European Commission.
Ferdinando Di Cunto is Professor of Molecular Biology at the University of Torino. He is member of the Italian Society of Biophisics and Molecular Biology (SIBBM), of the Italian Society of Neuroscience (SINS), of the Italian Cosiety of Biochemistry (SIB), of the Italian Society of Bioinformatics (BITS), and of the American Society of Cell Biology (ASCB). Since many years he has developed his research activity in both the experimental and computational biology fields. In the first field, he has been mainly studying the role of cytoskeletal control pathways in the proliferation and in the differentiation of mammalian neuronal precursors, with a specific focus on the involvement of these mechanisms in microcephaly. In the second field, he has concentrated on the development of computational methods for integrative genomics and systems biology. His research activity has been supported by MURST/MIUR, Telethon Foundation, University of Torino, San Paolo Bank Foundation, Piedmont Region, Fondation Jèrome Lejeune, Italian Ministry of Health, Cavalieri Ottolenghi Foundation and lately by Italian Association for Cancer Research (AIRC). FDC serves as peer reviewer for several prestigious scientific Journals and is Associate Editor of PLoS-ONE.
Prof Dimitriou obtained his medical qualification from the University of Athens, Greece, and subsequently gained clinical experience in paediatrics through his work in the general paediatric wards, paediatric A&E, and the neonatal intensive care unit (NICU). After completing his specialist training in neonatology in Greece, he spent several years as a Clinical Research Fellow, Lecturer and L.Consultant in the Department of Child Health at King’s College Hospital in London, where he obtained a PhD in neonatal respiratory muscle function.
He is currently Professor in Paediatrics and Neonatology and Chairman of the Department of Paediatrics, NICU, PICU at the University of Patras Medical School, Greece, President of the executive board of the Hellenic Neonatal Society and treasurer of the Union of European Neonatal and Perinatal Societies (UENPS).
His main research interests are lung function and respiratory muscle function, optimization of mechanical ventilation, neonatal infections. He has been invited to speak at workshops and conferences throughout Europe, acts as a referee for several prestigious paediatric and neonatal journals, and belongs to a number of national and European paediatric and research societies. He has published over 125 peer reviewed articles, widely cited by other authors.
Jon is a neonatologist and academic who as chief and local investigator has been involved in many neonatal trials. Amongst other studies, he has led the SIFT team studying the optimal speed of increasing milk feeds in preterm infants.
Professor Doyle is a neonatal paediatrician with a major research interest in evaluating the consequences of neonatal intensive care, including how to improve on that care, and its economic consequences. He has been a chief investigator on numerous randomised controlled trials of interventions before and after birth designed to improve the outcome for the highest-risk babies, including the tiniest and most immature babies. He is active with several research groups interested in the outcome for tiny babies well beyond the nursery and into adulthood; these are the Premature Infant Follow-up Programme at the Royal Women’s Hospital, the Victorian Infant Collaborative Study (VICS) Group, and the Victoria Infant Brain Studies (VIBeS) Group.
Jessica Dubois is a INSERM researcher in the Cognitive Neuroimaging Unit (U992, CEA/NeuroSpin, France), with a background in Physics and Neurosciences. Her works are focused on the early development of the brain studied with neuroimaging (MRI and EEG) in newborns and infants.
Afif graduated from Trinity College, Dublin in 2002 and enrolled in the Royal College of Physicians of Ireland paediatric specialist training scheme in 2005. He completed a Doctor of Medicine (MD) degree in University College, Dublin in 2008 and his neonatal specialty training in Toronto, Canada (2009-2011). Following this, he was appointed as a consultant Neonatologist and Assistant Professor of paediatrics at the University of Toronto in January of 2011. He obtained diploma in clinical epidemiology during his time in Toronto. Afif explored the use of novel technology in monitoring the haemodynamic status of preterm infants and was part of the only neonatal echo training course in Canada. He co-devised the world’s first echo teaching website and mobile device application. Recently, Afif have assumed a leadership role at a European level in devising training guidelines for echocardiography by the Neonatologist. In addition, he is the lead editor of the Haemodynamic Module in the NOTE project which offers a new international online Masters (M) level educational programme in neonatal medicine as collaboration between the European Society for Neonatology (ESN) and the Faculty of Health Sciences at the University of Southampton.
Martin Elliott is Professor of Paediatric Cardiothoracic Surgery at UCL & of Physic at Gresham College (http://bit.ly/2ibWP5f), London. He has been on staff at The Great Ormond Street Hospital for Children (GOSH) since 1984. He developed modified ultrafiltration, & helped set up thoracic transplantation, tracheal surgery and the clinical outcomes team at GOSH. @profmjelliott, www.martinelliott.me,
Mats Eriksson is a Professor in Nursing Science and a Specialist Nurse in intensive care.. His research area concerns infants, children and adolescents with special focus on pain and stress in newborn infants. He is the leader of the research group PEARL – Pain in Early Life, both at Örebro University and the international PEARL-group (www.pearl.direct). Mats is one of the principal investigators of the EU FP7-supported EUROPAIN -project studying pain management for critically ill newborns in 20 European countries. Mats is also member of the steering committée of the SANNI-project, working for safe analgesia in neonatal intensive care.
Trained in UK with time in Nottingham and Oxford. Moved to Australia in 1991 and since then have been Staff Specialist in Newborn Care at Royal Prince Alfred Hospital and Clinical Associate Professor at University of Sydney. Main interest in training and for use of ultrasound in acute neonatal care and neonatal haemodynamics.
Anders Fasth, MD, PhD, is Professor of Pediatric Immunology at University of Gothenburg, Gothenburg, Sweden. He established the Hematopoietic Stem Cell Transplantation Program at the Queen Silvia Children’s Hospital, Gothenburg as a treatment for immunodeficiencies, leukemias and other blood disorders and acted as its Medical Director since the start in 1984 and until 2011. He is also Medical Director of the Swedish National Cord Blood Bank at Sahlgrenska University Hospital, Gothenburg and Consultant Immunologist at the National Children’s Hospital, San José, Costa Rica since 1985. His main research interest lies in primary immunodeficiencies and pediatric rheumatology.
Dr Fasth earned his MD and PhD at the University of Gothenburg. He has also completed clinical and research fellowship at UCLA, CA, USA and at Hospital for Sick Children at Great Ormond Street, London, UK. He has authored or coauthored more than 230 scientific articles plus several textbook chapters. Dr Fasth has also served as chairperson of the Educational Working Committee of ESID and is a board member of the Swedish Primary Immunodeficiency Association.
Dr Fleiss’ overarching research interest is preventing disability in infants suffering perinatal brain injury, with a focus on the role of inflammation and strategies involving immunomodulation to facilitate repair. Her research specifically involves modelling perinatal insults in large and small animals to decipher mechanism of injury and test neurotherapeutics. In addition, Dr Fleiss integrates her data with analysis of clinical samples (MRI, genomics, serum biomarkers etc) to maximise the translational potential of her work. Dr Fleiss is a mid-career researcher with 40 publications and over 1000 citations and collaborators across multiple continents and specialities.
After graduation as a general nurse in 1986 Odile has been graduated for several nursing applications. Since 1993 Odile has been employed at the neonatology intensive care ward in the Sophia Children’s Hospital Erasmus MC Rotterdam.
In 2003 Odile graduated as a Master in Advanced Nursing Practice and she has been working as a neonatal nurse-practitioner since then.
Beside her clinical work Odile is the Vice president of the registration committee for Dutch nurse practitioners (verpleegkundig specialisten, RSV), a member of the scientific advisory board of the European Foundation for the Care of the Newborn infants (EFCNI), past president (2006-2015) of the Dutch association for nurse practitioners (V&VN VS), past nursing president of the European Society of Paediatric and Neonatal Intensive Care (ESPNIC)
Odile is an editorial board member of the online magazine Treatment In Paediatrics, member of the advisory board of the registration committe for Dutch Dentists and a member of the accreditation teams for the NVAO/RSV in 2014/2015.
In the past she participated in the commissions for the Dutch ministry of Health to advise in the legislation for nurse practitioners in the Netherlands. She was involved in the introduction of independent nurse prescribing in the Netherlands in 2012.
Since october 2013 she is one the knowledge ambassadors of the city of Rotterdam.
In September 2016 she goes back to school as a student MSc in quality and patient safety at the Radboud University in Nijmegen
Vivette Glover is Professor of Perinatal Psychobiology at Imperial College London. Her research has shown the effects of the emotional state of the mother during pregmnancy, both on the developing fetus and longer term on the child, and the biological mechanisms that may underlie such fetal programming. She has published over 400 papers. She has been an advisor to the Department of Health, the Early Intervention Foundation, the NSPCC, Best Beginnings and the biometric lead for A Better Start. Her work is contributing to changes in policy, with a growing awareness that better emotional care for women in pregnancy can improve the outcome for the next generation.
Prof. Göpel is neonatologist at the University of Lübeck and head of the German Neonatal Network, a cohort study focussed on long term development of premature infants and their genetic background.
Pierre Gressens received his Medical Degree (UCL, Brussels, Belgium) in 1989 and his Ph.D. at the University of Louvain Medical School (UCL) in 1995. He further specialized in Child Neurology and carried out his post-doctoral research training at the NIH (Bethesda, USA). He has been working at Robert Debré Hospital, Paris both a researcher and child neurologist since 1995.
Currently, he is the Director of the INSERM U1141 – Diderot University research laboratory, Consultant in the Department of Child Neurology at Robert Debré Hospital, Vice-dean for research at Paris Diderot Medical School, and Professor of Foetal and Neonatal Neurology at St Thomas’ Hospital (KCL, London, UK). Dr. Gressens’ laboratory has been involved with the basic and applied aspects of research in the area of diseases of the developing brain. He has put forward various novel concepts towards understanding the pathophysiology of perinatal brain damage and his current interests are aimed at improving therapeutic strategies to treat these brain damage.
He has published more than 260 original research papers (H index = 53) and more than 170 review papers and book chapters. More than 300 invited conferences and seminars are at his credit. Dr. Gressens has received several awards including the Jean Hamburger’s award from Paris City, the de Spoelbergh award, and the Guillaumat-Piel award.
Dr Hagberg is a consultant and Professor in Fetal Medicine at the Sahlgrenska Academy, Gothenburg, Sweden, and a chair at King’s College, London, UK, with a particular research interest in mechanisms of perinatal brain injury. Over the past 30 years, he has published 320 experimental and clinical original and review articles mostly focused on the roles of excitotoxicity, mitochondria, apoptosis and inflammation in perinatal brain injury. He has an H-index of 63 and a mean citation of 36/article.
Society for Neurochemstry Price to young investigator of the year (1990), Fernström’s price (1996), Recipient of a Fullbright Scholarship for one year (2000-2001) of research at Kennedy Krieger Institute, Johns Hopkins School of Medicine, Baltimore, USA and the Lennander award by the Swedish Medical Association (2008). He currently receives research grants from the Wellcome Trust (UK), Action Medical Research (AMR, UK), Medical Research Council (VR, Sweden), EU (ERA-NET) and ALF-LUA (Sweden). Dr Hagberg has supervised 31 Ph.D. students and 13 postdoctoral fellows.
TBH is a professor in neonatology with a special interest in perinatal epidemiology and neonatology: early exposures and long-term outcomes. She has some 300 international peer reviewed papers (H-index Scopus 54), and has supervised more than 30 PhD students, and reviewed a similar number. She is the founder of the Aarhus Birth Cohort and Biobank (1989 onwards) and is involved in the steering committee of a number of larger trials and organization of national and international teaching of PhD students and international conferences.
Professor Stuart Hooper is a NHMRC Principal Research Fellow and Director of the Ritchie Centre, Hudson Institute for Medical Research and Director of Research for the Department of Obstetrics and Gynaecology, Monash University. He is a fetal and neonatal physiologist whose research focuses on fetal and neonatal lung development and its transformation into a functional gas-exchange organ at birth. His research focuses on; (1) factors regulating lung growth, (2) the cardiovascular and respiratory transition at birth and (3) how respiratory support of very preterm infants can be improved to facilitate their transition at birth.
Prof. Petra Hüppi, is a clinician in pediatrics. Since 1998 she runs the Child Development Unit and the Division of Development and Growth at the Department of Pediatrics, Geneva University Hospitals, Switzerland. She received her MD from the University of Berne, where she trained in pediatrics, and newborn medicine at the Joint program in neonatology at Childrens Hospital, Harvard medical School, Boston.
Next to her clinical work, she is a full professor at the University of Geneva and has international research activities with a visiting scientist position at Harvard Medical School in Boston, USA.
She has directed numerous research projects both at Harvard Medical School and the University of Geneva, aimed at the better understanding of early human brain development. Her research has helped in a major way to understand the specific brain deficits found in prematurely born children, highly relevant for the cognitive and socio-emotional development of children and adolescents.
Her international status is further documented through her various commitments in major scientific societies and organizations. She serves as a Board of Trustee member of the International Society for Magnetic Resonance in Medicine (ISMRM) and the International Pediatric Resarch Foundation (IPRF) and is an elected member of the National Research Council of both Switzerland and France.
In order to join forces to study scientifically both the care and medical interventions on children’s long-term development, she founded the European association for developmental care (EADCare:http://www.eadcare.org/site/fr/contact)
Silvia Iacobelli, MD, PhD, full Professor of Pediatrics
Silvia Iacobelli is head of the NICU-PICU-neonatology department and medical coordinator of the Délégation à la Recherche Clinique et à l’Innovation at La Réunion University Hospital in St. Pierre, France. She is also a clinical research physician at the Centre d’Etudes Périnatales de l’Océan Indien (EA 7388) at the Université de La Réunion.
Professor Iacobelli received her medical degree from the Bari School of Medicine in Apulia, Italy. Subsequently, she completed residencies in paediatrics at both Bari University Hospital and the Université de Strasbourg, France. In 2013, she earned a PhD in epidemiology and public health from the Université de Bourgogne, France and became full Professor of Pediatrics in 2017. Her clinical interests include neonatal intensive care medicine, extremely low birth weight infant care, renal function in preterm babies, parenteral nutrition in newborn infants, and perinatal epidemiology, and her research has been published in numerous medical journals, including Neonatology, PLoS One, BMC Paediatrics, and the Journal of Clinical Pharmacology and Therapeutics. Additionally, she has authored or co-authored several book chapters and clinical reports. Board certified in paediatrics by the Bari School of Medicine, Professor Iacobelli is a member of the French Society of Neonatology, the French Society of Paediatrics, the Société Francaise de Pédiatrie de l’Océan Indien, a member of the Nutrition, Gastroenterology and Metabolism Council of ESPR, and 2015 expert working group (ESPGHAN, ESPEN and ESPR) to update the paediatric parenteral nutrition guidelines.
Dr Mark Johnson is a Consultant and Honorary Senior Lecturer in Neonatal Medicine at University Hospital Southampton NHS Foundation Trust. He has an active research programme at the NIHR Southampton Biomedical Research Centre in nutrition, which centres around the nutritional care and growth of preterm infants, nutritional assessment and the implementation of practice change in order to improve care. His work has also included the development of a neonatal nutritional screening tool and neonatal nutritional assessment. He has also undertaken several systematic reviews looking at the use of early parenteral nutrition in preterm infants, the impact of enhanced nutrition on the neurodevelopmental outcomes of preterm infants, and the effect of preterm birth on body composition and growth. He was successful in gaining a prestigious NIHR Doctoral Research Fellowship to fund his PhD in 2012, is a member of the BAPM working groups on parenteral nutrition and research skills training, and the ESPR Nutrition Section. Mark is also currently the lead for education and training for nutrition in the NIHR Southampton Biomedical Research Centre.
Dr. Sandra Juul completed her MD, residency, and fellowship at the University of Washington. To make further contributions to the field of Neonatology, she pursued and completed her Ph.D at the University of Chicago. Dr. Juul’s research focuses on the neurodevelopment and neuroprotection of at-risk newborns, primarily extremely preterm infants, and term infants with hypoxic ischemic encephalopathy, since both groups have outcomes of approximately 50% death or severe neurodevelopmental impairment. Her research lab includes basic science and translational studies in multiple animal models, including rodents, ferrets and nonhuman primates. She is the principal investigator for the Preterm Epo Neuroprotection Trial (PENUT) and co-PI of HEAL (High dose Epo for asphyxia and encephalopathy).
Gillian Kennedy is Consultant Speech and Language Therapist for Neonates /Paediatrics at UCLH and is one of two NIDCAP Trainers in the UK.
She undertook her undergraduate training in Edinburgh and developed a particular interest in swallowing, leading to her studying for an MSc at City University.
Following several years working with adults in both neurological and neuro-surgical settings, she brought many of the skills and knowledge gained in this clinical area to her work with preterm infants and high risk neonates and young children with neurological involvement. Over the past 25 years she has worked exclusively with premature infants and high risk neonates and their families.
Her work in supporting babies and their families in establishing feeding has been enhanced by her NIDCAP Training. Currently, she has particular interest in promoting comfortable digestion during tube feeding to facilitate the baby’s transfer to oral feeding.
Gillian progressed to becoming a NIDCAP Trainer and works collaboratively with Inga Warren, Senior Trainer at the UK NIDCAP Centre. She is a national advisor for therapies and regularly teaches both nationally and internationally.
She was appointed OBE in June 2015 for her work.
Contact email: firstname.lastname@example.org
Stephen graduated, in 1978, from Keble College, Oxford, in Experimental Psychology. He qualified in medicine at Guy’s Hospital in 1984, and then trained at the John Radcliffe Hospital, Oxford; Queen Charlotte’s & Chelsea Hospital, London, and the Royal Berkshire Hospital, Reading.
He held the posts of Research Fellow (1986-89), Clinical Lecturer (1992-94), and Senior Fellow in Reproductive Medicine (1994-99) in the Nuffield Department of Obstetrics & Gynaecology before being appointed to the post of Clinical Reader in 1999 and Professor of Reproductive Medicine in 2011. He has been Head of Department since 2005. He was Clinical Director, Women’s Services (2011-13) in the Oxford University Hospitals NHS Foundation Trust and has been Divisional Director, Children’s & Women’s Services since 2014.
He jointly leads INTERGROWTH-21st, a large-scale, multicentre project, funded by the Bill & Melinda Gates Foundation, involving over 60,000 mothers and babies and health institutions in 11 geographically diverse countries, that aims to assess fetal and newborn growth under optimal and various sub-optimal conditions (e.g. malaria, HIV and malnutrition), as well as the influence of these factors on the epigenome.
The key message of the INTERGROWTH-21st Project is that healthy, well-educated, well-nourished women who live in a healthy environment and receive adequate health care, have babies that grow in a similar way in the womb and achieve a similar size at birth irrespective of their ethnicity/race.
Dr. Carole Kenner is the Carol Kuser Loser Dean/Professor of the School of Nursing, Health, and Exercise Science at The College of New Jersey. Dr. Kenner received a Bachelor’s of Science in Nursing from the University of Cincinnati and her master’s and doctorate in nursing from Indiana University. She specialized in neonatal/perinatal nursing for her master’s and obtained a minor in higher education for her doctorate.
Her career is dedicated to nursing education and to the health of neonates and their families, as well as educational and professional development of healthcare practices in neonatology. She helped develop the End of Life Nursing Education Consortium (ELNEC) Neonatal/Pediatric modules. She serves on the Consensus Committee of Neonatal Intensive Care Design Standards, which sets recommendations for Neonatal Intensive Care Unit designs and serves on the March of Dimes Nursing Advisory Committee. She is a fellow of the American Academy of Nursing (FAAN), a fellow in the National Academies of Practice, a Fellow in the Academy of Nursing Education, past president of the National Association of Neonatal Nurses (NANN) and founding President of the Council of International Neonatal Nurses (COINN), the first international organization representing neonatal nursing-setting standards globally. She is the 2011 recipient of the Audrey Hepburn Award for Contributions to the Health and Welfare of Children internationally.
Dr Elsa Kermorvant is Associate Professor in Pediatrics at Paris Descartes University and serves as attending neonatologist in the NICU of Necker-Enfants malades Hospital in Paris. She holds a PhD degree from Paris Descartes University.
Her special clinical interests include neonatal nutrition and congenital malformations. Her basic science research activities have been focusing on perinatal factors that influence retinal development and retinopathy of prematurity since her postdoctoral fellowship in the Department of Pediatrics, Ophthalmology and Pharmacology, Saint-Justine Hospital Research Center in Montreal, Canada, under the direction of Prof. Sylvain Chemtob. Her current work is centered specifically on the consequences of neonatal hyperglycemia on the developing retina.
She is also very active in the field of medical education, especially in simulation-based education in the Simulation Center of Paris Descartes University.
She is a member of the Board of the French Society of Neonatology (SFN).
Kai König trained in Hamburg and Berlin, Germany, in general paediatrics and paediatric intensive care, before relocating to Melbourne, Australia, in 2006, where he completed his neonatal training and worked as a consultant neonatologist at the Mercy Hospital for Women und the Royal Children’s Hospital between 2008 and 2013. In 2013, he continued working as a consultant neonatologist and paediatric intensivist at the Children’s Hospital Lucerne, in Switzerland, before moving into primary care paediatrics in 2016. He is one of three paediatricians in a busy paediatric practice in the centre of Lucerne, Switzerland. Having worked on both sides of neonatal care, he is very much interested in improving the transition of high-risk newborns from their stay in the neonatal intensive care unit into the primary care setting.
Pierre Kuhn is a senior neonatologist, Professor of pediatrics and head of the Neonatal Intensive Care Unit at the University Hospital of Strasbourg (France). His research focusses on the sensory sensitivities of preterm infants, on the evaluation of the impact of the hospital environment on brain development and of developmental care strategies. His PhD in Neuroscience focussed on the auditory sensitivity of preterm infants. He has spent one full year in Stockholm at the Karolinska Institute (KI) as an invited researcher and still collaborates with the neonatal research unit of Astrid Lindgren Hospital at KI. He is also the co-founder and co-coordinator of the Group of Reflection and Evaluation of the Environment of Newborns of the French Neonatal Society (GREEN de la SFN). He is the co-chair of the Topic Expert Group on “Infant and family centred developmentally supportive care” of the European foundation of the Care of Newborn Infants.
Satyan Lakshminrusimha is the Chief of the Division of Neonatology, Professor and Vice Chair of Pediatrics at University at Buffalo. His research focuses on transition at birth, neonatal resuscitation and the role of oxygen and nitric oxide in disorders of transition. His passion is to transfer innovative ideas from bench to the isolette/NICU and mentoring junior facultyr. Drawing medical illustrations is his hobby. His complete bibliography can be found at Complete bibliography at http://www.ncbi.nlm.nih.gov/myncbi/browse/collection/41161156/?sort=date&direction=ascending
Beatrice Latal MD MPH Dr. Latal is the Co-Director of the Child Development Center at the University Children’s Hospital Zurich. She leads a large research group and is dedicated to teaching and faculty development.
In her research, she investigates the developmental outcome of newborns and children at risk for neurodevelopmental disorders. This includes children born very prematurely, children with hypoxic-ischemic encephalopathy (“perinatal asphyxia”) and children with severe congenital heart disease.
Dr. Latal’s main research goals are to characterize the prevalence and severity of neurodevelopmental impairments in these children, to identify the potential risk factors for impairments and to study the mechanisms involved in the etiology of brain injury. Dr. Latal also examines the application of diagnostic tools such as amplitude integrated EEG, cerebral MRI and neurological examination for their potential usefulness as outcome predictors. Outcome research is becoming more important with the increasing survival rates achieved thanks to major improvements in intensive care medicine and general care. A better understanding of the mechanisms involved in the etiology of brain injury in these high-risk children will allow for neuroprotective drug therapies and other interventions. Such interventions will improve the neurodevelopmental outcome and quality of life of these vulnerable patients and will ensure an optimal integration into adult life.
Prof. dr. Jos Latour is Professor in Clinical Nursing at Plymouth University in Plymouth, UK. His clinical post is based at Derriford Hospital in Plymouth and Musgrove Park Hospital in Taunton in the UK where he is the director of the Clinical Schools aiming to drive clinical research and trials. The research lines of Prof Latour are family involvement in care and clinical trials, patient and family centred care, end-of-life care practices, and paediatric sepsis. He is an associate-editor of Pediatric Critical Care Medicine and editorial board member of several other international peer-reviewed journals.
Dr. Shoo Lee is a neonatologist and health economist. He is Scientific Director of the Institute of Human Development, Child and Youth Health (IHDCYH) at the Canadian Institutes of Health Research; Professor of Paediatrics, Obstetrics & Gynaecology and Public Health; Paediatrician-in-Chief and Director of the Maternal-Infant Care (MICare) Research Centre at Mt. Sinai Hospital and Senior Clinician Scientist of the Lunenfeld-Tannenbaum Research Institute.
Dr. Lee received his medical degree from the University of Singapore, completed his paediatric training at the Janeway Children’s Hospital in Newfoundland and neonatal fellowship training at Boston’s Children’s Hospital, and received his PhD in Health Policy (Economics) from Harvard University.
As the founder and Chairman of the Canadian Neonatal NetworkTM and the International Neonatal Collaboration, Dr Lee fosters collaborative research, and he leads the CIHR Team in Maternal-Infant Care. His research focuses on improving quality of care, patient outcomes and health care services delivery. He developed Family Integrated Care model and piloted the concept at Mount Sinai Hospital.
Awards for his work include the CAPHC 2016 Contribution to Child Health Award, SPR Douglas K. Richardson Award for Perinatal & Pediatric Healthcare Research, CIHR Knowledge Translation Award, the Aventis Pasteur Research Award and the Distinguished Neonatologist Award from the Canadian Paediatric Society, the Premier Member of Honour Award from the Sociedad Iberoamericana de Neonatologia, Magnolia Award from the Shanghai government and Honorary President of the Xiamen Children’s Hospital from the Xiamen government.
Professor Liisa Lehtonen leads the Division of Neonatology at Turku University Hospital which granted the status of Center of Excellence. Her research focuses on developing the neonatal care to optimize the outcome of preterm infants. She has developed family centered care and is one the developers of the Close Collaboration with Parents training program.
Petra Lemmers was graduated in medical science at Leiden University in the Netherlands (cum laude) and was trained in pediatrics at the Sophia Children’s Hospital/Erasmus University Hospital Rotterdam (NL) and in neonatal medicine in the Isala Clinics Zwolle (NL) and the Wilhelmina Children’s Hospital/University Medical Center Utrecht (NL).
At the present time she is associate professor in neonatology (research school Child Health, University Medical Center Utrecht), she is working as an expert of the customer excellence program ‘Samen voor de Patient’ in the University Medical Center Utrecht and as a consultant neonatologist at the NICU of the Wilhelmina Children’s Hospital Utrecht.
The main focus of research on this NICU is the neonatal brain: brain monitoring, brain hemodynamics, neuroprotection, brain imaging and neurodevelopmental outcome (prof Manon Benders and prof Linda de Vries). In 2003 she started her research concerning the clinical use of non-invasive cerebral monitoring by near infrared spectroscopy (NIRS) in (preterm) neonates admitted on the NICU. She defended her thesis “The clinical use of near infrared spectroscopy‐monitored cerebral oxygen saturation and extraction in the preterm infant” in 2010 and published until now > 60 peer reviewed papers about this subject in prominent scientific journals.
Nowadays on the NICU the brain of preterm infants, neonates after perinatal asphyxia and all infants undergoing surgery in the neonatal period are monitored by NIRS during the most vulnerable period after birth: during transition, during treatment with hypothermia, but also during surgery.
She also participates in national and international collaborative projects concerning NIRS (SafeBoosc-trial: prof Gorm Greisen Kopenhagen Denmark; TOHOP-trail/cerebral hemodynamics: prof Istvan Seri Los Angeles USA, currently Doha Quatar; NIRS-project concerning monitoring cerebral autoregulatory ability: prof Gunnar Naulaers and prof Sabine van Huffel Leuven, Belgium. She is supervising several PhD students and is involved in education and training programs concerning brain monitoring in neonates in the Netherlands and abroad.
Silke Mader is the Chairwoman of the Executive Board and co-founder of EFCNI. In 1997, her twins were born in the 25th week of pregnancy, and were not given the appropriate care. Unfortunately, one of them died a few days after birth, leaving the parents and the sibling behind. During her time in hospital and afterwards, she was faced with the non-existence of support of any kind, the absence of public awareness and the lack of information and education for parents during pregnancy. She felt that no parents should ever undergo such an awful experience again.
Silke Mader is author, co-editor and technical editor of reports and publications on the situation of preterm birth and newborn health in Europe and beyond.
In 2012 Silke Mader was awarded the “Prix Courage” in Germany. 2013 she received the Medal for Particular Services to Bavaria in a United Europe. Since 2014 she is Honorary Lecturer at the School of Nursing and Midwifery, Queen’s University Belfast, Northern Ireland. In 2015, Silke Mader has been awarded as social entrepreneur and Ashoka Fellow. At the ALL Ladies League (ALL) – Women Economic Forum 2016 in New Delhi, India, Silke Mader received the “Iconic Innovative Trailblazer of the Decade” award. During an official ceremony in Nuremberg on 14 October 2016, Silke Mader was awarded with the Bavarian State Medal for Services concerning Health and Long-term Care by Melanie Huml, the Bavarian State Minister for Health and Long-term Care.
Daniel is an adult Critical Care Physician at the Royal Free Hospital in London and Reader in Perioperative and Critical Care Medicine at University College London. His main research interest is human adaptation to hypoxia and how to improve survival in hypoxic critically ill patients. He has a particular interest how the microcirculation and tissue oxygen utilisation play a role in this. Daniel is the Director of the UCL Centre for Altitude, Space and Extreme Environment (CASE) Medicine, was the expedition leader of Xtreme Everest 2 (XE2 2013) and Xtreme Alps (XA 2010) studies and played a key role in the Caudwell Xtreme Everest (CXE 2007) study. When he summited Mount Everest in May 2007 as part of CXE 2007 the measurements from arterial blood taken near the summit revealed him to have the lowest level of oxygen ever reported in a human (NEJM, 2009).
Professor Carolyn McGregor AM is the Canada Research Chair in Health Informatics based at the University of Ontario Institute of Technology. She received her bachelor of applied science in computer science honours (1st class) degree, and her PhD degree in computer science from the University of Technology, Sydney. In the 1990s she led two of the earliest business analytics implementations in Australia for one of the largest banks and the largest retailer and went on to provide strategic advice to several large organisations in Australia for their management of analytics data.
Since 1999 Dr McGregor has led pioneering research in Big Data analytics, real-time stream processing, temporal data mining, patient journey modelling and cloud computing. She now progresses this research within the context of critical care medicine, mental health, astronaut health and military and civilian tactical training.
She has been awarded over $11 million in research, consultancy and infrastructure funding and has led multiple large research programs including a multi-million dollar First of A Kind (FOAK) research program with IBM. She has over 160 refereed publications, 3 patent in multiple jurisdictions and has established two startup companies resulting from her research. She has extensive research collaborations in Canada, China, USA, Russia, Australia and India. She has also been called upon to advise various government working groups in Canada. She has received many awards for her research and in 2014 she was awarded membership in the Order of Australia for her significant service to science and innovation through health care information systems. In 2016-17 she serves as the Chair of the IEEE Life Sciences Technical Community internationally. In 2017 she was featured in the 150 Stories series commissioned by the Lieutenant Governor of Ontario and the Government of Canada to commemorate the 150th year anniversary of Ontario.
Patrick McNamara graduated from Queens University Belfast in 1987, received his MRCPCH in Pediatrics in 1997 and Certificate of Completion of Specialist Training in Neonatal Medicine in 2002. He is currently a Staff Neonatologist and Director of Clinical Research within the Division of Neonatology at the Hospital for Sick Children, and Professor of Pediatrics and Physiology, University of Toronto. He is the chair of the Canadian Targeted Neonatal Echocardiography working group and the Chair of the Canadian Neonatal Resuscitation Program. He is the current chair of the International Paediatric Academic Society Neonatal Hemodynamics Collaborative. His clinical and research interests include myocardial performance in the settings of a hemodynamically significant ductus arteriosus, pulmonary hypertension and targeted neonatal echocardiography.
Dr. Miller is Head of the Division of Neurology and Centre for Brain and Mental Health at SickKids. He is a Senior Scientist in Neurosciences & Mental Health program in the SickKids Research Institute. He is a Professor in the Department of Paediatrics at the University of Toronto and holds the Bloorview Children’s Hospital Foundation Chair in Paediatric Neuroscience.
Collaborating with a multidisciplinary team, Dr. Miller’s research program focuses on better understanding brain injury and development in the newborn. He and his team use advanced brain imaging and detailed long-term follow-up to help children who were born early or with conditions that put them at risk of neurological and developmental deficits. He has contributed to our understanding of brain abnormalities caused directly by premature birth, perinatal asphyxia or indirectly by congenital heart disease.
Professor of Neonatal Medicine at Imperial College London, Consultant at Chelsea and Westminster Hospital, and President of the UK Royal College of Paediatrics and Child Health.
Neena leads a neonatal research programme focused on the perinatal determinants of life-long health. She led the development of the UK National Neonatal Research Database, an internationally unique “big-data” resource on all admissions to neonatal units in England, Wales and Scotland, used for a wide range of national and international research, quality improvement, audit, and surveillance outputs. Neena is extensively published in peer-reviewed journals, has authored a number of chapters in textbooks, commentaries and reviews, and directs the well-known “Neonatal Update: The Science of Newborn Care”, a week-long international academic meeting held in London each December.
Neena has made many contributions to children’s services. She has been at the forefront of reinvigorating the clinical research base of paediatrics and child health, and has championed opportunity for research experience for all paediatricians. She has served on many working parties and committees, and has held a large number of national roles including President of the UK Neonatal Society, President of the Academic Paediatrics Association of Great Britain and Ireland, Chair of the British Medical Journal Ethics Committee, and Chair of the NHS England Infant, Children and Young People Patient Safety Expert Group.
Sissel J Moltu is a neonatologist and post-doctoral researcher at the Department of Neonatal Intensive Care, Oslo University Hospital, Norway. She qualified as a physician from the Albert-Ludwig-University in Germany and completed her training in pediatrics and neonatology in Norway and the United Kingdom. In 2005 she received her specialist degree in Pediatrics and worked several years as a consultant in pediatric gastroenterology and nutrition, before she in 2014 obtained her PhD in neonatal nutrition from the University of Oslo. For the last few years, the focus of her clinical and research activities has been neonatal nutrition, particularly the roles of early nutrition on growth, metabolism and inflammation
Professor Eleanor Molloy is the Professor and Chair of Paediatrics at Trinity College Dublin. She is a paediatrician and neonatologist based in the National Children’s Hospital, Tallaght, the Coombe Women’s and Infants’ University Hospital and Our Lady’s Children’s Hospital, Crumlin, Dublin, Ireland.
Professor Molloy qualified in Medicine in University College Cork and received her Ph.D. from University College Dublin in 2003. Her research is concerned with interdisciplinary child health research and the promotion of paediatric translational projects to improve child health. Specifically, she is interested in the evaluation and modulation of systemic inflammation in newborn infants with brain injury and the also the development of neonatal palliative care.
Professor Molloy is currently the Irish Representative on the Executive Committee of the UK Academic Paediatric Association, the European Editor of the journal Pediatric Research, and council member of the European Society for Paediatric Research.
Dr Colin Morgan began his longstanding interest in neonatal nutrition by studying neonatal long chain polyunsaturated fatty acid absorption in preterm and term infants. In 1999, he became Senior Lecturer in Neonatal Medicine at University College London (Royal Free Hospital) and moved to the Liverpool Women’s Hospital as Consultant Neonatologist in 2004. He is a regular contributor to educational packages explaining the scientific rationale for early enteral and parenteral nutritional strategies in term and preterm infants. He also has a particular interest in postgraduate medical education and advanced nursing practice. He is currently Head of School (Paediatrics) for Health Education England North West. His current research interests focus on neonatal parenteral nutrition formulations and the impact of early neonatal nutrition on postnatal metabolic adaptation, brain growth and neurodevelopment outcome in very preterm infants. He is also actively involved in a number of projects improving the quality and safety of early nutritional interventions in neonatal clinical practice including the use of standardised parenteral nutrition and donor breast milk.
Immediately following my degree I focused on neonatal resuscitation techniques and respiratory assistance, collaborating in the clinical trials of the first apparatus for mechanical ventilation and positive pressure applied through nasal cannulas. Research in this sector, facilitated by in-depth study of respiratory physiopathology during the Course of Specialization in Anaesthesiology and Resuscitation, led to the design and implementation of an automatic neonatal and paediatric ventilator (MOG 2000 ventilator – 1989).
The MOG 2000 was among the first neonatal ventilators to have graphic monitoring of the pressure wave and related parameters, and the possibility of carrying out assisted ventilation through a pressure trigger. This ventilator was successfully used for many years in the Neonatal Intensive Care Unit of the Sapienza University of Rome and in other Neonatal Intensive Care Units in universities and hospitals in Italy and abroad. The evolution of assisted ventilation techniques and the possibility of also using them on low-birth-weight children has enabled the implementation and trial of a monitor to detect airflow at the tracheal cannula level so as to synchronize ventilator activity with the spontaneous breathing of the patient (flow-synchronized assisted ventilation). This method of ventilation was subsequently also applied using nasal cannulas in newborns and infants affected by respiratory disease (non-invasive flow-synchronized ventilation) and led to the patenting of a neonatal non-invasive ventilator that enables tracheal intubation of patients to be avoided or at least its duration significantly reduced.
Long-term attendance at the Departments of Resuscitation, Heart Surgery, Obstetrics and in particular Paediatric Surgery at the Sapienza University of Rome, has allowed me to further extend my clinical experience in the field of neonatal and paediatric anaesthesia, resuscitation and bronchoscopy.
Thanks to extensive experience gained in the field of neonatal and paediatric emergency, in 2003 I was put in charge of the reorganization of the Clinical Paediatrics Accident and Emergency and Observation Department of the Sapienza University of Rome, followed by the implementation of the new Paediatric Intensive Care, in effect since January 2005.
Lastly, I would like to highlight my considerable commitment to teaching and research leading to the publication of numerous articles and chapters in international journals and books, and of two volumes on respiratory physiopathology and neonatal and infant ventilation techniques.
Dr Deirdre Murray graduated from UCC in 1995 and trained in Paediatrics in Dublin, before specialising Paediatric Intensive Care in leading International Paediatric Hospitals: the Royal Bristol Children’s Hospital and the Royal Children’s Hospital in Melbourne, Australia. She returned to Ireland to persue a dedicated research post and completed the first PhD in the Department of Paediatrics, UCC in June 2008. This thesis focussed on early continuous EEG in neonatal brain injury.
She took up her post as Senior Lecturer in the Department of Paediatrics and Child Health in 2008 and has developed her research interest into early brain injury and neurodevelopmental outcome since that time. Her aim is to improve long term neurological outcome through improved detection, prediction and early intervention following neonatal brain injury. Dr Murray is the Principal investigator of the Cork BASELINE Birth Cohort Study and through this study, funded by the National Children’s Research Centre has established a large extremely well phenotyped birth cohort with the first neonatal biobank in Ireland. In 2012 she was the first Irish Paediatrician to be awarded the prestigious HRB Clinician Scientist Award to develop her research in the field of novel biomarkers in Hypoxic-Ischaemic Encephalopathy through the BiHiVE study. In 2013 she became one of 9 Principal Investigators in the Irish Centre for Fetal and Neonatal Translational Research (INFANT centre).
- Consultant in charge of paediatric cardiology and consultant in neonatology at Dept. of Paediatrics, Vestfold Hospital Trust, Tønsberg, Norway
- Postdoctoral researcher at the Center for Cardiological Innovation, Oslo University Hospital and the University of Oslo (http://www.heart-sfi.no/)
- Philosophia doctor, University of Oslo 2010 (Thesis: “Longitudinal strain and strain rate by tissue
Doppler in term neonates:
- Specialization in Paediatrics and Neonatology 2005
- MD University of Oslo, 1997
- Section board member of the “Circulation, Oxygen Transport and Haematology” section in the European Society for Paediatric Research
- Section board member of the Working Group of Echocardiography in the Norwegian Society of Cardiology [Norsk Cardiologisk Selskap]
- I have in PhD- and postdoc-positions since 2005 done research in cardiology and neonatology with focus on the interplay between newborn circulation and heart function, especially the transitional phase from fetal to newborn circulation and assessment of heart function by ultrasound in healthy and sick newborns. I have put down much effort in improving the methods used for assessing myocardial function by ultrasound, including a patent pending (“Choosing variables in tissue velocity imaging”) and several papers.
- In my current research position at the Center for Cardiological Innovation, my main research topics in adult cardiology are on developing new echocardiographic methods for identification of myocardial scars. Further, I participate in the SysAFib-project, an EU-project aiming at developing novel diagnostic tools by use of machine learning (advanced computer modelling, “big data”) for treatment of patients with atrial fibrillation.
Research group, supervising tasks, and international contacts and cooperation:
I am a senior member of the research group NeoCHIBS (Neonatal Circulation, Heart, Infection and Brain Study Group) at the Oslo University Hospital/University of Oslo, led by Professor Drude Fugelseth. NeoCHIBS is an internationally leading group on echocardiographic assessment of heart function in neonates, with national and international collaborators. Within the group, I am principal supervisor in a PhD project on functional echocardiography in intra-uterine growth restriction, “The transition at birth of hepatic, cardiac and cerebral circulation, blood flow distribution, and myocardial function in term and preterm infants with intrauterine growth restriction”. PhD-candidate is MD Lisa Bjarkø. I have acted as a co-supervisor in one PhD project in functional echocardiography and as a co-worker in a second PhD project in functional echocardiography within the group. November 2016, one group member (MD, PhD Sissel Moltu) received a 12M NOK grant from The Research Council of Norwegian for a project on nutrition in premature neonate (the IMNuT trial). Part of the project will focus on short- and long-term heart function outcome, as a PhD project where I will act as principal supervisor. The group is also the Norwegian collaborator in the ALBINO project (http://cordis.europa.eu/project/rcn/199013_en.html), an EU multicentre trial on treatment of neonates suffering from perinatal asphyxia. Norwegian study coordinator is associated professor Tom Stiris. The primary outcome in the ALBINO trial is survival and neurodevelopmental outcome. We have implemented heart function as a secondary objective in the ALBINO trial, and I will be responsible for the heart function assessment.
At Vestfold Hospital Trust, I run the CHOPS trial, studying advanced echocardiography to improve diagnostics in neonates with congenital heart disease. I also administer two epidemiologically based quality health registers in the Vestfold region of Norway, one for children with congenital heart disease and one for neonatal intensive care transportation.
I am a member of an international group of 25 researchers in neonatal cardiology and neonatology, (the Special Interest Group for Neonatologist performed Echocardiograph) formed by the European Society for Paediatric Research and The European Society for Neonatology. The group develops guidelines for functional echocardiography in neonatal intensive care.
Other academic merits and qualifications:
- Academic co-worker (“faglig medarbeider”) in Paediatrics for the Journal of the Norwegian Medical Association (“Tidsskr Nor Laegefor”)
- First author of a novel chapter on functional echocardiography in the upcoming issue of the National Guidelines in Paediatrics (Generell veileder i pediatri) to be finalized in May 2017, issued by the Norwegian Paediatric Association
- Referee tasks include the peer review journals Acta Paediatrica, Early Human Development, PLOS ONE, Ultrasound in Medicine and Biology, and Neonatology, and peer reviews of international clinical research fellowships
- Experienced computer user with good knowledge in advanced use of computer software (MS Office, SPSS, Sigmaplot, and Adobe).
- Master advanced statistics, including mixed models statistics
The Center for Fetal & Neonatal Medicine, Division of Neonatology,
Children’s Hospital Los Angeles, Keck School of Medicine,
University of Southern California, Los Angeles, CA, USA
Chiara Nosarti, Reader in Neurodevelopment and Mental Health in the Department of Psychosis Studies and Head of Psychology and Outcome Studies, Centre for the Developing Brain, King’s College London, is a cognitive neuroscientist whose research focuses on the study of neurodevelopmental outcomes following very preterm birth, using multimodal neuroimaging. A current research interest is the application of cognitive training programmes and the study of training-induced neuroplasticity. Dr Nosarti has published extensively in these areas and has served as Principal Investigator on various studies supported by the March of Dimes and the National Alliance for Research on Schizophrenia and Depression (US), the Medical Research Council, the National Institute for Health Research Biomedical Research Centre for Mental Health, Cerebra and Newlife Foundation (UK).
Dr. Won Soon Park is a Professor of Pediatrics at Samsung medical Center, Sungkyunkwan University, School of Medicine, Seoul, Korea.
Dr. Park’s research interest is the stem cell transplantation for intractable neonatal disorders including bronchopulmonary dysplasia, severe hypoxic ischemic encephalopathy and intraventricular hemorrhage.
Julia Petty is a Senior Lecturer in Children’s Nursing at University of Hertfordshire (UH) where she has worked since April 2013. Julia’s role at UH comprises teaching and assessment for a variety of child health modules including leading a module focusing on care of the sick child and a generic nursing module in professional aspects of care.
Prior to UH, she worked at City University, London for 12 years where she ran a portfolio of neonatal post-qualifying modules as part of the BSc Nursing programme. She has an extensive educational background in the neonatal specialty including a role of new-born life support instructor for the UK Resuscitation Council. She is link lecturer for a range of children’s and neonatal nursing clinical practice placements. Julia has a keen interest in the development of digital learning resources in neonatal and children’s nursing and has contributed regularly to publications in this as well as other related subjects. She is currently in the early stages of undertaking a Doctorate in Education exploring how a case study approach can be used to understand the patient journey and design specific curricula for learning in neonatal care.
Christian Poets, MD, is Professor of Paediatrics at Tuebingen University. He graduated from Hannover Medical School in June 1986 and received his medical and scientific training at the Dept. of Paediatric Pulmonology & Neonatoloy, Hannover Medical School, Hannover, and at the Dept. of Paediatric Respiratory Physiology, National Heart & Lung Institute, London, UK. In 1994, he became consultant paediatrician, in charge of the Neonatal Intensive Care Unit and the Paediatric Sleep Lab in Hannover, and was appointed Head of the Department of Neonatology at Tuebingen University in 2002. In 2007, he became speaker of the newly founded Centre for Craniofacial Malformations at Tuebingen University Hospital. He also served as president of the Society for Neonatology and Paediatric Intensive Care from 2006-2010. His main research interests lie in the control of breathing, oxygen monitoring, innate immunity, neonatal clinical studies and epidemiology. He is actively involved in large RCTs, e.g. on the effects of inhaled steroids and automated oxygen control, respectively, on neurologically intact survival and BPD prevention in extremely low gestational age infants. He has co-authored >290 articles cited in PubMed and has contributed to over 120 review articles. He is a member of the Neonatal Society (London) and Society of Neonatology & Paediatric Intensive Care (Germany).
Margo Pritchard is Australia’s first appointed Clinical Chair in Neonatal Nursing, a joint position with the Australian Catholic University and Mater Hospitals. She is a Registered nurse, midwife with advanced neonatal nurse training. Her key research areas are addressing screening, surveillance and interventions needs in infants and families cared for in neonatal intensive care units, the importance of the early years and contributing to the evidence base about what works to address these needs. She is well published and has a Research Quality Rating of 5.
Heike Rabe is a Neonatologist working in Brighton, UK. Her research interests are providing extra placental blood to babies at birth, neonatal adaptation and providing age appropriate drugs for newborn babies.
The main focus of my research over the last five years is injury and repair of the pulmonary vascular system. This has included studies into ventilation of newborns with congential lung malformations. From 2008 to 2014, I was principal investigator of a multicentre randomized controlled trial comparing two ventilation strategies in infants with congenital diaphragmatic hernia. We were able to show that initial conventional ventilation might be more beneficial than high-frequency oscillation in these children.
Furthermore, my research included antenatal and postnatal adaptive processes in fetus/newborns with intrauterine growth restriction. We have shown that fetal Doppler patterns are predictive of outcome in severely intrauterine growth restricted infants.
Also, we are studying placental development and the role of the nitric oxide system in normal and abnormal pregnancies. We are establishing an ex-vivo placental perfusion model to study the effects of various pharmacological compounds on placental function with the aim of therapeutic strategies and conducting clinical trials to improve fetal and maternal outcome (in close collaboration with the Departments of Obstetrics and Gynaecology and Vascular Pharmacology).
In the last two years, my research is focusing on the effects of antenatal and postnatal environmental factors on adaptation. This work includes both studies into the effects of oxygen and into the circadian rhythm. We have developed systems that measure and administer optimal oxygen concentrations postnatally. This will lead to a better postnatal management of premature infants. In close collaboration with the Department of Molecular Genetics, we are performing animal studies to examine the effects of social jetlag before and after delivery.
I am a neonatologist and professor of perinatal neuroscience with an interest in brain neuroimaging and neuroprotection. I lead a research group focused on developing a pipeline of safe and effective therapies to augment hypothermic neuroprotection in neonatal encephalopathy. I am interested in neuroprotection that works in all settings across the world and am currently working on Ghana to assess the best strategies to improve outcomes.
Charles Christoph Roehr (M.D., PhD.) is a neonatal intensivist and clinical researcher, currently serving as consultant and honorary Senior Clinical Lecturer, University of Oxford, Newborn Services, John Radcliffe Hospital, Oxford, UK. His special interests include neonatal stabilization and resuscitation as well as non-invasive respiratory support.
After receiving his medical degree in Germany (Berlin), he continued his clinical training at the Charité University Medical Centre in Berlin, in Oxford, UK and in Melbourne, Australia. Following the completion of his research and teaching degree (Habilitation) at the Charité Berlin, he spent almost 2 years as post-doc researcher in Melbourne, Australia (2012-14) before taking up his current position.
An avid researcher and a strong proponent of evidence-based neonatology, he has published over 70 peer reviewed scientific articles, mainly on non-invasive ventilation, pulmonary function and neonatal stabilization.
Dr Roehr is very active within the ESPR/ ESN as the officer of education, European Society of Neonatology (ESN) and is a council member and President-Elect of the European Society of Neonatology (ESPR). He also presently chairs the European Scientific Collaboration of Neonatal Resuscitation Research (ESCNR).
Karl Rombo is one of the founders and the vice chairman of the Swedish parent organization Svenska Prematurförbundet, as well as a professional operasinger and medical student at Karolinska Institutet, Stockholm. Karl is very involved in the patient issues regarding premature babies in Sweden and has given a number of presentations both in public and to HCP:s about his experinces as a father. He was also key speaker at the Jens Pre-congress in Budapest 2016. Karls daughter is now well and constantly singing her way through life”
Professor of Pediatrics at University of Oslo. Director of Department of Pediatric Research, Oslo University Hospital.
Umberto Simeoni is Professor of Paediatrics at Faculté de Biologie et de Médecine, University of Lausanne and Director of the Division of Pediatrics and of the Developmental Origins of Health and Disease (DOHaD) Research Unit at CHUV University Hospital in Lausanne Switzerland.
His research is oriented towards the Developmental Origins of Health and Disease (DOHaD), with a special focus on the developmental programming of the cardio-vascular system in conditions of perinatal disease, such as intrauterine growth-restriction, preterm birth or exposure to maternal overweight/obesity and gestational diabetes. He also is highly interested in perinatal bioethics. Umberto Simeoni is Past-President of the European Association of Perinatal Medicine and President of the Société Francophone DOHaD.
I started my research career studying the effects of pain and morphine in preterm infants. Afterwards I did some research on the effects of pain and morphine on the brain in a rat-model. Since then I became interested in neonatal pharmacology in all its aspects. Currently, I am involved in neonatal PK/PD research, dose
finding studies and other clinical trials. Next to that I have a special interest in pharmacological aspects of pregnancy and the placenta.
It is important to realize that pharmacology and drug therapy are involved in almost all fields of
Improved pharmacological knowledge, determination of the correct drug dosages for newborns at different maturational stages, better registration of effects and side-effects would be beneficial for all neonates at the NICU. In the search for new (protective) drug therapies pharmacology is crucial.
Collaboration with the other sections and fields within neonatology is our ambition: Neuroprotection, lungprotection, pharmaco-nutrition and metabolism, better antibiotic dosing, improved knowledge of
circulatory failure and hypotensive treatment, new interventions, etc. Education of basics of
pharmacology and PK/PD is essential for all scientists and clinicians involved in the care of critically ill newborns.
Next to that I am involved in TULIPS. Training Upcoming Leaders in Pediatric Science is a Dutch nonprofit organization that aims to improve the health of children by training clinician scientists within the field of child health. It is our vision that better researchers would improve the health of children.
We have established a training and career development program for young researchers: Grant writing, time management, coaching, mentoring, networking, etc… all skills that might be necessary to become a successful researcher are trained. I am very interested and willing to share our experiences with others in Europe.
Dr Yogen Singh is a Consultant Neonatologist and Paediatrician with Expertise in Cardiology with equal responsibilities in Neonatology and Paediatric Cardiology at Cambridge University Hospitals in the UK. He is an Associate Lecturer at the University of Cambridge and also holds an Honorary Consultant position at Great Ormond Street Hospital London.
He has special interest in neonatal haemodynamics, functional echocardiography and advanced functional echocardiography imaging. He is the lead author for the “Expert Consensus Statement on Neonatologist Performed Echocardiography (NPE): Training and Accreditation in the UK”. He is a member of the European neonatologist Performed Echocardiography Steering group, who have published European NPE guidelines. He is an educational, academic and research lead at the Paediatrician with Expertise in Cardiology Special Interest Group (PECSIG) executive committee and also a lead for the accreditation and training at NICHe (Neonatologist with Interest in Cardiology and Haemodynamics) group UK.
Yogen is a co-founder and course director at ‘Yorkshire Paediatric Echocardiography Course’ and a course director at ‘Cambridge Paediatric and Neonatal Echocardiography Course’. He has facilitated more than 20 functional echocardiography workshops / courses in UK, Europe, USA and beyond.
Please visit his website: www.dryogensingh.co.uk for further information.
As a neonatologist and developmental pediatrician I am interrested in developmental brain injury. My research looks at alteration of the developing brain with: Neuropathology, neuroimaging (MRI), functional evaluation and neuroprotection (drugs and nutritional intervention). Activities and projects in basic science research and clinical research: acute preterm brain injury, developmental brain injury in intra-uterine growth restriction. Further developmental care and its effect on brain development is part of my interrests.
Dr. Subhedar is a Consultant Neonatologist working at Liverpool Women’s Hospital. He qualified from the University of Bristol in 1988 and trained in Bristol, Liverpool and Brisbane, Australia. He was awarded an MD in 1998 for research into neonatal pulmonary hypertension and inhaled nitric oxide therapy. He has a clinical and research interest in cardiorespiratory disorders and echocardiography in neonates. He led the first randomised controlled trial of inhaled nitric oxide in preterm neonates and currently chairs the European Inhaled Nitric Oxide Registry.
Pierre Szepetowski, born 1960, MD, PhD, CNRS Director of Research (DR1), is heading the EPIPATH research team at the Mediterranean Institute of Neurobiology (INMED, INSERM U901, Aix-Marseille University). He is a honorary professor of Changsha University, China, and a member of the Administrative and of the Scientific Advisory Boards of the French League against Epilepsy (LFCE). His group has long been focusing on the relationships between various pediatric epileptic and nonepileptic pathological conditions on the one hand, and brain development and maturation on the other hand.
He has coordinated multi-level studies that included human genetics, molecular and cell biology, immunohistochemistry, electrophysiology, in utero intracerebroventricular electroporation, phenotype characterization, and therapeutic assays in animal models. In the recent years his group has recently identified key epilepsy genes; notably he demonstrated the role of NMDA receptor subunit gene GRIN2A in patients and families presenting with the epilepsy-aphasia spectrum of disorders, and of the PRRT2 gene in variably associated infantile convulsions, paroxysmal dyskinesia, and hemiplegic migraine. He has also demonstrated that postnatal epileptic activity caused by in utero neuronal migration defect in the rat embryonic brain could be prevented by early and short drug administration during pregancy. He has also recently put a strong interest in the design and the validation of a rat model of cytomegalovirus infection of the developing brain, in which the brain immune system is prominently altered.
Nicole Thiele joined EFCNI in 2010 and holds the position of Vice Chair of the Executive Board of the European Foundation for the Care of Newborn Infants (EFCNI). In this function, she is involved in the overall management of the Foundation, from daily business to developing the long-term strategies, campaigning or communication tools with different key stakeholders in the maternal and newborn health arena, with the aim to improve maternal and newborn health across Europe and beyond and enhancing the collaboration between patients, healthcare professionals, researchers and other key stakeholders.
Nicole developed declarations, guidelines and educational and information material targeting parents and families of preterm children, the general public and other stakeholders. She is author, co-author and co-editor of different reports and papers.
With her family experiencing the consequences of an extremely preterm birth at the beginning of modern neonatology, she is personally committed to drive forward the prevention of prematurity and particularly the philosophy of family centred, developmentally supportive care and parental inclusion in care, crucial contributors to give a baby the best chances at life and to develop to their full potential.
Martijn van den Heuvel has a background in Cognitive Artificial Intelligence. A decade back, Martijn became fascinated by the emerging field of ‘brain connectomics’. Inspired by the view that brain function does not merely result from single regions but emerges from interactions between brain regions, he now works in the field of ‘MRI brain connectomics’, unraveling the underlying principles of network wiring of the brain, in health and disease. With his expertise he bridges several disciplines, such as mathematics, informatics, psychology and medicine.
Agnes van den Hoogen is a nurse scientist and teacher at the University Medical Centre of Utrecht (UMCU) – Wilhelmina Children’s Hospital in Utrecht, The Netherlands.
In January 2000, she graduated in Clinical Health Science (Cardiff University, Wales, UK).
September 2009 she obtained her PhD at the University of Utrecht, medical faculty of the University Medical Centre Utrecht. Topic thesis: Infections in Neonatal Intensive: Care Prevalence, Prevention and Antibiotic use. Promoter: Professor F. van Bel MD.
Clinical Interest: Neonatal infections, Management of Intra Venous access in Neonates, Family Centred and Integrated Care, Family Empowerment, Sleep in neonates, Ethics, Epidemiology and Education.
Current professional situation:
• Postdoc researcher at the NICU of the Wilhelmina Children’s Hospital, UMCU
• Qualified in education and teacher at the University of Utrecht, The Netherlands in clinical health science. Topics of education are systematic literature research, Science in transition, Quality of Care and mentoring academic students in research
• Coordinating education and involved in curriculum development
• Engaged in various educational activities regarding neonatal health care
• Member of Call to Action, Netherlands. To achieve the Millennium Development Goal for child survival (MDG-4, to reduce Global Maternal, Neonatal, and Child Morbidity and Mortality)
• Member of the Scientific Advisory Board of the EFCNI (European Foundation for the care of newborn infants)
• Vice Chair Education and training for nurses and midwives in EFCNI for Standards of Care for Newborn Health in Europe (education and training)
• Board of Directors of the Counsel of International Neonatal Nurses (COINN)
• Involved in scientific program committee of jENS 2017
Agnes was president of the European Society for Paediatric and Neonatal Intensive Care (ESPNIC) form 2009-2013 and member of the scientific board since 2006 and from March 2016 till January 2017 secretary. Honorary member of ESPNIC.
Member of Sigma Theta Tau International, Honor Society of Nursing Rho Chi- Chapter et large.
Member of Dutch research group of neonatal nurses.
Bert van der Horst received his PhD in Cell Biology at the Erasmus University Rotterdam in 1993, where he studied the lysosomal enzyme sialidase. As a postdoctoral fellow at the Department of Molecular Genetics, Erasmus MC, he has generated and characterized a large panel of (conditional) animal models for DNA repair disorders, associated with skin cancer predisposition and/or premature aging (e.g. Cockayne syndrome), as well as for mammalian homologs of the repair protein photolyase (mCry1 and mCry2). Unexpectedly, the mCry genes were shown to encode indispensable components of the biological clock, a major breakthrough in the field of chronobiology. For the latter work he received a prestigious ZonMW Vici award that stood at the basis of a new research line in the Department, focusing on the molecular mechanism and biological impact of the circadian system.
By integrating running research lines on the circadian clock, genome instability and aging in a new multidisciplinary research direction, and by applying state of the art technology (i.e. conditional mouse models, clock-synchronized cultured cells, transcriptomics/next generation sequencing, in vivo imaging in cells, tissues and animals), the Chronobiology & Health research group aims at obtaining fundamental knowledge on the biological/medical impact of the circadian system. Special emphasis is on the origin and treatment of diseases (i.e. cancer, age-related disorders) including the adverse effect of chronic circadian disturbance (i.e. shift work) thereon. Recently, the group became interested in how pre- and postnatal environmental conditions may influence the programming of the circadian system and how this may impact on later life health. Ultimate goal is to translate obtained knowledge into applications to prevent or delay onset of health problems (preventive intervention) and into new clinical approaches in cancer and other drug-based therapies (personalized medicine, chronotherapy).
Anton van Kaam is currently professor of neonatology and the chief of the neonatal intensive care units at the Emma Children’s Hospital in the Academic Medical Center and the VU university medical center in Amsterdam, The Netherlands. He did his medical and pediatric training in Rotterdam at, respectively, the Erasmus Medical Center and the Sophia Children’s Hospital. Following his certification in 1997 he moved to the Emma Children’s Hospital in Amsterdam, where he did is training in Neonatology until 1999. Since then, he has been working as a consultant in Neonatology and obtained his PhD degree in 2004.
In 2010 he was appointed chief of neonatology at the Emma Children’s Hospital AMC and, in addition, in 2017 at the VU university medical center. In 2014 he was appointed as full professor of neonatology. His main research interest is on lung physiology, control of breathing, respiratory support, ventilator induced lung injury and lung protective ventilation in neonatology. In this field he has done both experimental and clinical research. He is currently also involved in large national and international clinical trials.
Eduard Verhagen, is a paediatrician at the University Medical Center Groningen (Netherlands). Dr Verhagen completed his specialty training in Paediatrics in AMC/Amsterdam. He worked for 5 years in Curaçao (Caribbean) before he came to Groningen to work as the clinical director of the Beatrix Children’s Hospital/UMCG, where he is now a professor of paediatrics and department chair.
He received his MD and JD from the University of Utrecht (Netherlands) and completed his pediatric specialty training in Amsterdam. His PhD thesis (University of Groningen) was on neonatal end-of-life decisions in Dutch NICU’s. He has written numerous scientific papers about ethical decision-making and end-of-life care and he was one of the authors of the ‘Groningen Protocol’ for newborn euthanasia. He leads several national research and paediatric palliative care initiatives and functions as a member and chair of several national and governmental medical-ethical and legal advice councils.
Dr Karen Walker is a Clinical Associate Professor with both Sydney Nursing and Sydney Medical School at the University of Sydney. She is a Clinical Research Fellow in Grace Centre for Newborn Care at the Children’s Hospital at Westmead in Sydney, a Senior Research Fellow with the Cerebral Palsy Alliance and a member of the international steering committee for the International Multi-disciplinary Prevention and Cure Team for Cerebral Palsy (IMPACT for CP). She has more than 50 publications and has presented at over 100 national and international conferences. She is the current president of the Australian College of Neonatal Nurses and Vice President of the Council of International Neonatal Nurses.
Dr Suellen Walker MBBS MMed MSc PhD FANZCA FFPMANZCA FPMRCA Dr Suellen Walker MBBS MMed MSc PhD FANZCA FFPMANZCA FPMRCA Reader and Consultant in Paediatric Anaesthesia and Pain MedicineDr Walker’s clinical practice involves inpatient and outpatient paediatric pain medicine. Her clinical and translational laboratory research relates to the developmental neurobiology of pain, developmental pharmacodynamics of analgesics, and long-term effects of neonatal pain.
MD, PhD, resident in paediatrics
Jonathan Wells completed a degree in social anthropology, an MPhil in biological anthropology, and a PhD in biological anthropology and nutrition, all at the University of Cambridge. Following post-doctoral research at the MRC Dunn Nutrition Unit in Cambridge, he moved to UCL Institute of Child Health where he is now Professor of Anthropology and Pediatric Nutrition. His research focuses on pediatric body composition and energy metabolism, with emphasis on the developmental origins of adult disease in the context of global health. He also develops and applies evolutionary theory to elucidate the association between developmental plasticity and health.
Consultant Neonatologist, Leader of Fetal and Neonatal Stress Research Group, and Lecturer at the University of Basel
PhD, Dr rer. nat . h.c. Dipl-Psych, C.Psychol, AFBPS
Professor of Developmental Psychology and Individual Differences
University of Warwick, Department of Psychology and Warwick Medical School (UK)
Dieter studied at the University of Kiel (Germany) and University of London and obtained his PhD from the University of London, Faculty of Science. He has worked at different colleges of the University of London (Institute of Education; King’s College; Institute of Child Health) and the Universities of Munich, Hertfordshire (chair) and Bristol (Chair in Lifespan Psychology, Deputy Director of the Avon Longitudinal Study (ALSPAC)). Before his appointment at the University of Warwick, he worked in the research funding sector (Scientific Director of the Jacobs Foundation, Zurich, 2004-2006) while holding Visiting Professorships at the University of Bristol and University of Zurich.
Much of his research is interdisciplinary (psychology, social and medical sciences), longitudinal and in the field of Developmental Psychopathology. His major research topics are: 1. early regulatory problems in infancy and their long term consequences; 2. how preterm birth affects brain development and psychological development and quality of life; 3. Peer or sibling victimization (bullying): precursors, consequences and interventions. He is involved as PI/Co-PI in a range of follow-up studies in the UK and Germany including the ALSPAC cohort, EPICure Study and the Bavarian Longitudinal Study. He is a Co-PI of the UK Household Longitudinal Study (Understanding Society), the largest longitudinal panel study in the world including some 100.000 people with special interest in biomarkers. He is a co-manager of the Horizon 2020 RECAP project involving 12 countries trying to improve the lives of preterm children. He works with several charities and has been involved in a number of intervention studies ranging from how neonatal discharge can be improved (e.g. midwife training), how to deal with excessive crying and infant regulatory problems or virtual intervention to deal with bullying victimization. He is currently collaborating in a trial of managed transition from adolescent psychiatric services into adult psychiatric services (EU wide project: Milestones).
Dieter teaches undergraduate students in Developmental Psychopathology and in the M.Sc. in Clinical applications. He has supervised dozen of PhD students and leads the Lifespan Health and Wellbeing Research Group in his home department. He has published widely in leading journals (Google scholar H-Index 72; approx. 18.500 citations) and is on the editorial boards of a number of journals and several scientific advisory boards. He is actively engaged in dissemination activities to the public and policy makers to raise awareness of the long term effects of preterm birth and bullying victimization on mental health. His work is regularly picked up by the media and in recent feature news articles in Nature and the New Scientist. Most importantly, to conduct large studies it is important to collaborate and he is working with scientists from the USA, Canada, Australia and across Europe.
Nature Feature: http://www.nature.com/news/neuroscience-the-brain-interrupted-1.16831
New Scientist Feature: https://www.newscientist.com/article/2077401-premature-birth-how-its-effects-can-stay-with-you-for-life
Bullying and Plastic Surgery: http://www.dailymail.co.uk/health/article-4455002/School-bullies-likely-seek-plastic-surgery.html
Crying in babies: variations by countries: https://www.theguardian.com/society/2017/apr/03/babies-crying-britain-canada-italy-denmark-germany-japan
Professor Luc J.I. Zimmermann was born in 1959 in Belgium. He graduated as MD in 1984 at the Catholic University of Leuven, Belgium and did his residency in Pediatrics at the same university, in the University Hospital Gasthuisberg Leuven, Belgium (1984-1989).
He trained as a Fellow in Neonatology at the Hospital for Sick Children and the University of Toronto Perinatal Fellowship Program in Toronto, Canada from 1989 to 1992. From 1992 to 2003 he was a staff Neonatologist at the Erasmus Medical Center – Sophia in Rotterdam, where he was Chief of the Division of Neonatology a.i. from 2000 to 2003.
His PhD thesis (in 1995) was titled “Regulation of CTP:phosphocholine cytidylyltransferase in fetal type II cells”. In 2003 he became a staff neonatologist at the Academic Hospital Maastricht, in 2004 Professor in Pediatrics and in 2005 Chief of the Division of Neonatology.
In 2006 he became Chairman of the Department of Pediatrics and Director of the Residency Program in Pediatrics (currently, he is deputy chairman of the residency program). Since 2006 he is also Division Leader of the Division Developmental Biology in the research school “Oncology and Developmental Biology-GROW”.
His main research interest is in neonatal lung development and related neoanatal lung problems.
Since 2012 he is President of the European Society for Paediatric Research.
He was (co-) organiser of several (inter)national meetings and conferences, such as the Fetal and Neonatal Physiology Society meeting in Maastricht 2008, the European Society for Paediatric Research conference in Porto 2013, the European Academic Pediatric Societies conferences in Barcelona 2014 and Geneva 2016, the European Conference on Perinatal Medicine in Maastricht 2016, the Joined European Neonatal Societies Conference in Budapest 2015 and the future Joined European Neonatal Societies Conference in Maastricht 2019.